The TOGETHER-PsA study shows that combining ixekizumab with tirzepatide leads to significantly better psoriatic arthritis ...
MedPage Today on MSN
Not All Drugs Approved for Rheumatoid Arthritis Are Equal for Pain Relief
Both upadacitinib (Rinvoq) and adalimumab (Humira) are proven effective in rheumatoid arthritis (RA) and psoriatic arthritis ...
Treatment with apremilast proved safe and effective over a 48-week period for the management of early oligoarticular psoriatic arthritis. Apremilast (APR) shows significant efficacy and safety over 48 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback